Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$461M |
| 2 |
Deutsche Bank
DB
|
+$435M |
| 3 |
NVIDIA
NVDA
|
+$310M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 5 |
Sempra
SRE
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$791M |
| 2 |
Microsoft
MSFT
|
+$436M |
| 3 |
Zscaler
ZS
|
+$346M |
| 4 |
Bank of America
BAC
|
+$274M |
| 5 |
Broadcom
AVGO
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.04% |
| 2 | Financials | 13.18% |
| 3 | Healthcare | 10.51% |
| 4 | Communication Services | 9.68% |
| 5 | Consumer Discretionary | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Dr. Reddy's Laboratories
RDY
$9.87B
| $2.71M | ﹤0.01% |
180,417
+29,730
| +20% | +$425K |
|
1502
Prestige Consumer Healthcare
PBH
$2.38B
| $2.71M | ﹤0.01% |
33,923
-5,907
| -15% | -$494K |
|
1503
Korn Ferry
KFY
$4.18B
| $2.7M | ﹤0.01% |
36,872
-3,890
| -10% | -$259K |
|
1504
BlueLinx
BXC
$422M
| $2.7M | ﹤0.01% |
36,278
-9,394
| -21% | -$657K |
|
1505
iShares Core S&P US Growth ETF
IUSG
$31.7B
| $2.7M | ﹤0.01% |
+17,931
| New | +$2.43M |
|
1506
Cogent Communications
CCOI
$676M
| $2.69M | ﹤0.01% |
55,801
-7,045
| -11% | -$358K |
|
1507
Exponent
EXPO
$3.24B
| $2.68M | ﹤0.01% |
35,907
-30,464
| -46% | -$2.36M |
|
1508
Pebblebrook Hotel Trust
PEB
$2.15B
| $2.68M | ﹤0.01% |
268,061
-85,217
| -24% | -$792K |
|
1509
ICU Medical
ICUI
$4.21B
| $2.68M | ﹤0.01% |
20,252
+44
| +0.2% | +$5.96K |
|
1510
ThredUp
TDUP
$746M
| $2.67M | ﹤0.01% |
356,796
+314,145
| +737% | +$1.85M |
|
1511
Evolus
EOLS
$385M
| $2.67M | ﹤0.01% |
290,039
-5,523
| -2% | -$56.5K |
|
1512
Woodward
WWD
$21.3B
| $2.66M | ﹤0.01% |
10,867
+6,062
| +126% | +$1.24M |
|
1513
Krystal Biotech
KRYS
$10.1B
| $2.63M | ﹤0.01% |
19,135
-2,602
| -12% | -$382K |
|
1514
Herc Holdings
HRI
$5.02B
| $2.63M | ﹤0.01% |
19,948
-25,387
| -56% | -$3.08M |
|
1515
Celldex Therapeutics
CLDX
$2.99B
| $2.62M | ﹤0.01% |
128,581
-9,708
| -7% | -$189K |
|
|
CURB
1516
Curbline Properties
CURB
$3.52B
| $2.61M | ﹤0.01% |
114,374
+28
| +0% | +$644 |
|
1517
Endava
DAVA
$158M
| $2.6M | ﹤0.01% |
169,855
+97,568
| +135% | +$1.64M |
|
1518
Green Dot
GDOT
$743M
| $2.6M | ﹤0.01% |
241,222
-10,246
| -4% | -$92.6K |
|
1519
Insight Enterprises
NSIT
$3.89B
| $2.6M | ﹤0.01% |
18,824
-4,327
| -19% | -$583K |
|
1520
KT
KT
$8.62B
| $2.6M | ﹤0.01% |
125,000
| – | – |
|
|
SOBO
1521
South Bow Corp
SOBO
$7.74B
| $2.59M | ﹤0.01% |
100,079
+1,734
| +2% | +$44.1K |
|
|
VMEO
1522
DELISTED
Vimeo
VMEO
| $2.59M | ﹤0.01% |
641,328
-255,120
| -28% | -$1.18M |
|
1523
Champion Homes
SKY
$4.37B
| $2.59M | ﹤0.01% |
41,347
-10,879
| -21% | -$846K |
|
1524
StepStone Group
STEP
$3.61B
| $2.59M | ﹤0.01% |
46,620
-8,342
| -15% | -$447K |
|
1525
Boise Cascade
BCC
$2.69B
| $2.56M | ﹤0.01% |
29,485
-33,338
| -53% | -$3.02M |
|
Similar funds
Deutsche Bank's Q2 2025 Portfolio in Review
As of Q2 2025, Deutsche Bank held 3,800 positions worth $272B, up 7.6% from $252B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Deutsche Bank's Q2 2025 filing shows 197 new, 1,017 increased, 1,982 reduced and 197 closed positions. Its largest new stake was Amrize Ltd: 4,354,301 shares worth $216M. The largest sale was UnitedHealth, an estimated $791M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Deutsche Bank's largest Q2 2025 buy was Amrize Ltd: 4,354,301 shares worth $216M.
- Deutsche Bank added most to Apple in Q2 2025, an estimated $461M increase.
- Deutsche Bank's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $791M.
- Deutsche Bank fully exited Discover Financial Services in Q2 2025, selling an estimated $189M.
- Deutsche Bank's ten largest holdings make up 27% of its $272B portfolio in Q2 2025.
- Deutsche Bank opened 197 new positions and closed 197 in Q2 2025.
- Deutsche Bank's portfolio value rose 7.6% quarter-over-quarter to $272B.
Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.